Using Amigurumi Toys to Reduce Pain and Fear in Children During Blood Collection
Effect of Therapeutic Play Applied With Amigurumi Toys During Blood Collection on Children's Pain and Fear
This study is testing if playing with cute amigurumi toys can help reduce pain and fear in young children during blood draws.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 4 Years to 6 Years |
| Sex | All |
| Sponsor | Recep Tayyip Erdogan University Academic / other |
| Locations | 1 site (Rize, Güneysu) |
| Trial ID | NCT06746506 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of therapeutic play with amigurumi toys in alleviating pain and fear during blood collection in children aged 4 to 6 years. Conducted at the pediatric emergency department of Recep Tayyip Erdoğan University, the study will involve a randomized controlled design with 80 participants. Data will be collected using various assessment tools, including the Wong-Baker Facial Expression Assessment Scale and the Child Fear Scale, to measure outcomes. The trial will run from December 2024 to June 2025, focusing on children who meet specific eligibility criteria.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 4 to 6 years who are outpatients requiring blood collection due to acute illness.
Not a fit: Patients who have chronic or life-threatening diseases, or those with developmental disorders, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce pain and fear in young children undergoing blood collection, improving their overall experience.
How similar studies have performed: Previous studies have shown positive outcomes using therapeutic play techniques, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 4-6, * Those who applied to the hospital as outpatients due to an acute illness, * Those who were rated as yellow triage in the 3-level (red-yellow-green) triage system, * Those whose mother or father was with the child during the procedure, * Those whose blood was drawn with a single procedure, * Those whose health status was stable will be included in the study. Exclusion Criteria: * - Children who have a history of sedative, analgesic or narcotic substance use within 24 hours before application, * Children with a fever higher than 38 °C, * Children with visual, hearing, language development, mental and neurological disorders, * Children with a chronic or life-threatening disease, * Children who refuse to participate in the study, * Children who are treated in the red or green zone according to the triage system (red = critical emergency, requiring immediate action; yellow = unstable condition, requiring intervention within 60 minutes; and green = stable condition, intervention should be performed within 2 hours) will not be included in the study.
Where this trial is running
Rize, Güneysu
- Recep Tayyip Erdogan University — Rize, Güneysu, Turkey (Recruiting)
Study contacts
- Study coordinator: Gamzegül ALTAY
- Email: gamzegulaltay25@gmail.com
- Phone: 05456119296
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.